Cipherome
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $16M
Investors
- 4
About Cipherome
Based in California, US, and founded in 2015, Cipherome, Inc. operates as an Artificial Intelligence (AI) and bioinformatics company, focused on the development of a technology platform, intended to predict ADRs (Adverse Drug Reactions) related to various medications, thereby allowing patients to receive quality and safe treatment and care. Cipherome, Inc. develops and offers a patented technology platform called Xentinel®, that uses artificial intelligence (AI) to analyze an individual's genetic variants or genomics, as well as clinical factors like weight, patient age, chronic diseases, medications, and so on, to predict the risk for adverse drug reactions (ADRs) in patients who consumes a specific drug. The company's technology enables healthcare professionals to personalize medication to a specific patient, thereby reducing the effects of ADRs, while ensuring quality patient care.
Who invested in Cipherome
4 investors across 1 round
See all investors in Cipherome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 14, 2022
Amount
$16M
Investors
Questions about Cipherome
Who invested in Cipherome?
Cipherome has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cipherome raised?
Cipherome has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cipherome last raise money?
Cipherome's most recent round on record is a Series B, in Feb 2022.
What does Cipherome do?
Based in California, US, and founded in 2015, Cipherome, Inc.
Where is Cipherome headquartered?
Cipherome is headquartered in San Jose, US.
Which VCs invest in companies like Cipherome?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cipherome's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cipherome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.